Sub-millimetric, patient-specific brain targeting for functional neurosurgery and real-world outcomes in Parkinson’s Disease and Essential Tremor.

Focused Ultrasound Foundation Highlights RebrAIn’s AI Innovations in Neurosurgery

We are excited to share that the Focused Ultrasound Foundation has featured RebrAIn for our pioneering use of artificial intelligence in brain targeting.

The article details how our supervised AI-driven platform, Optim MRI, enhances precision and effectiveness in neurosurgical procedures such as Deep Brain Stimulation (DBS). This innovative technology, developed by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, aims to improve patient outcomes and expand treatment options.

Discover our groundbreaking work by reading the full article.

Our latest public updates

RebrAin 2025/2026: Expanding Reach, Driving Innovation

RebrAin 2025/2026: Expanding Reach, Driving Innovation

Jan 5, 2026

Transatlantic expansion RebrAIn’s focus for 2026 is expanding our reach to major neurosurgery reference centers in the US and Europe. Today, our top partner centers by volume are Duke University, University of Virginia (UVA), Pamplona and UCLA. These collaborations...

Rebrain publishes OPTIVIM trial results in Neurosurgery

Rebrain publishes OPTIVIM trial results in Neurosurgery

Dec 5, 2025

An innovative and automated method RebrAIn’s service is based on a machine learning model trained on data from successfully treated patients. Using only a standard 3D T1 MRI, the algorithm automatically computes the stereotactic coordinates of the optimal DBS target,...